Testing effectiveness (Phase 2)Active Not RecruitingNCT06314490
What this trial is testing
Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A
Who this might be right for
Genetic Disease
University of California, San Diego 1